JPRN-UMIN000003507已完成2 期
Phase II trial of neoadjuvant chemotherapy with XELOX plus Bevacizumab for locally advanced rectal cancer - N-SOG 03
agoya Surgical Oncology Group0 个研究点目标入组 30 人开始时间: 2010年4月20日最近更新:
适应症
试验速览
- 阶段
- 2 期
- 状态
- 已完成
- 发起方
- 入组人数
- 30
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 20years-old 至 80years-old（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •1. Multiple malignacies to be treated 2. Uncontrollable peptic ulcer disease 3. Serious complications 4. Previous history of severe drug-induced allergy 5. Severe neuropathy 6. With interstitial lung disease or pulmonary fibrosis 7. Pregnant 8. Prior chemotherapy with bevacizumab, oxaliplatin or capecitabin 9. Disqualified by attending docor
研究者
相似试验
招募中
2 期
Phase II Trial of neoadjuvant chemotherapy with docetaxel, cisplatin and 5-FU for advanced esophageal canceresophageal cancerJPRN-UMIN000007408Second Department of Surgery, Wakayama Medical University40
招募中
不适用
A phase II trial of neoadjuvant chemotherapy with docetaxel,cisplatin and S-1 (DCS) for radically resectable advanced gastric carcinoma (KDOG 1001)radically resectable advanced gastric carcinomaJPRN-UMIN000003642Kitasato University School of Medicine40
招募中
2 期
Phase II study of the neoadjuvant chemotherapy of GEM/nab-PTX for biological borderline-resectable pancreatic cancerC535836pancreatic cancerJPRN-jRCT1041230068Ebata Tomoki50
招募中
2 期
A phase II trial of neoadjuvant chemotherapy using the combination of gemcitabine and cisplatin for patients with initially unresectable locally advanced biliary tract cancer.Biliary tract cancer (Intrahepatic cholangiocarcinoma, Extrahepatic cholangiocarcinoma, Gallbladder carcinoma)JPRN-UMIN000015330Adjuvant therapy for BTC Research Group50
未知
2 期
A Phase II trial of neoadjuvant chemotherapy with S-1 and fractional cisplatin for locally advanced gastric cancerGastric cancerJPRN-UMIN000001777Division of Biological Regulation and Oncology, Department of Surgery, Graduate School of Medicine, Tohoku University25